Arden Trust CO Gsk PLC Transaction History

Arden Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 09, 2020	SELL	$37.87 - $43.58 $166,590 - $191,708	-4,399 Closed	0 $0
Q1 2020 Apr 16, 2020	SELL	$32.47 - $48.83 $34,548 - $51,955	-1,064 Reduced 19.48%	4,399 $167,000
Q4 2019 Jan 17, 2020	SELL	$42.0 - $48.25 $5,082 - $5,838	-121 Reduced 2.17%	5,463 $257,000
Q3 2019 Oct 09, 2019	SELL	$40.46 - $43.52 $19,339 - $20,802	-478 Reduced 7.89%	5,584 $238,000
Q2 2019 Jul 23, 2019	BUY	$39.4 - $42.7 $238,842 - $258,847	6,062 New	6,062 $242,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.1B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.